Primary study · included by 1 review
Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer Patients
Hollingsworth 2016 · Hollingsworth Brynn, Senter Leigha, Zhang Xiaoli, et al. · The Journal of Clinical Endocrinology & Metabolism · 2016
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · between 2 and 6 months after RIT | Prevalence 0.37 [0.28, 0.47] | 4 studies · 392 participants | GRADE not reported |
1 including review in total.